University of Pennsylvania / Abramson Cancer Center — Philadelphia, Pennsylvania

University of Pennsylvania / Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pennsylvania / Abramson Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Cancer, Metastatic Cancer, Ovarian Cancer.

Sponsors: Artios Pharma Ltd.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania / Abramson Cancer Center?

University of Pennsylvania / Abramson Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania / Abramson Cancer Center conducted?

University of Pennsylvania / Abramson Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Cancer, Metastatic Cancer, Ovarian Cancer.

Is University of Pennsylvania / Abramson Cancer Center accredited by Crixeo Health?

University of Pennsylvania / Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania / Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.